3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Completed
5
Unknown
3
Recruiting
3
Active not recruiting
2
Terminated
1
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
37
Gastrointestinal
23
Genitourinary
20
Thoracic
14
Lymphoid
13
Other hematologic neoplasm
9
Head & Neck
8
Other
7
Gynecologic
6
Dermatologic
4
Plasma cell
3
CNS
3
Sarcoma
1
Endocrine
1
Conditions
Multiple Myeloma
494
Lymphoma
52
Recurrence
49
Neoplasms, Plasma Cell
49
Immunoglobulin Light-chain Amyloidosis
43
Neoplasms
35
Lymphoma, Non-Hodgkin
35
Leukemia
34
Hematologic Neoplasms
32
Myelodysplastic Syndromes
28
Smoldering Multiple Myeloma
27
Leukemia, Myeloid, Acute
26
Leukemia, Plasma Cell
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Monoclonal Gammopathy of Undetermined Significance
18
Hodgkin Disease
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Amyloidosis
17
Lymphoma, B-Cell
15
Breast Neoplasms
14
Ovarian Neoplasms
12
Paraproteinemias
11
Myeloproliferative Disorders
10
Colorectal Neoplasms
10
Primary Myelofibrosis
9
Melanoma
9
Lymphoma, Follicular
9
Infections
9
Prostatic Neoplasms
8
Lymphoproliferative Disorders
8
Interventions
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Motor Activity
×
Plasma cell
×
Clear all
NCT07547007
2026-04-23
BAPAMM
Centre Hospitalier Metropole Savoie
Phase NA
Recruiting
86 enrolled
NCT07290309
2026-03-31
SURGE
Colorado State University
Phase NA
Recruiting
300 enrolled
NCT06280924
2026-02-06
MOTIVATE
University of Alberta
Phase NA
Recruiting
30 enrolled